Alzheimer's Disease Update.

This article presents news briefs related to the treatment of Alzheimer's disease. One of the snippets report that Neurologix Inc. has licensed a promising new gene for the treatment of Alzheimer's and other central nervous system disorders from Keio University in Tokyo, Japan as part of a strategic move to broaden its product portfolio. Another snippet presents information on the U.S. National Institute on Aging that has awarded $9 million to the University of California in Irvine, California to support research into Alzheimer's disease and to help fund the development of pioneering treatments. The five-year Alzheimer's Disease Research Center grant, which will support more than 30 University of California, Irvine faculty investigators, renews an expiring $6 million grant from the National Institute on Aging.